Detalhe da pesquisa
1.
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma.
Cell
; 179(2): 417-431.e19, 2019 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585081
2.
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma.
Cell
; 180(2): 406, 2020 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978350
3.
A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production.
Nat Immunol
; 15(12): 1162-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25362490
4.
Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe Chronic Obstructive Pulmonary Disease.
Am J Respir Cell Mol Biol
; 70(5): 414-423, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315810
5.
The effects of inhaled corticosteroids on healthy airways.
Allergy
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686450
6.
A genome-wide association study of chronic spontaneous urticaria risk and heterogeneity.
J Allergy Clin Immunol
; 151(5): 1351-1356, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343773
7.
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control.
J Allergy Clin Immunol
; 152(4): 876-886, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315813
8.
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis.
Crit Care
; 27(1): 234, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312169
9.
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Am J Respir Crit Care Med
; 206(5): 545-553, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549845
10.
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis.
J Allergy Clin Immunol
; 150(6): 1517-1524, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041655
11.
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma.
J Allergy Clin Immunol
; 150(4): 972-978.e7, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487308
12.
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Eur Respir J
; 59(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561291
13.
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma.
Allergy
; 77(10): 2974-2986, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579040
14.
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation.
Pulm Pharmacol Ther
; 75: 102133, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644305
15.
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial.
J Allergy Clin Immunol
; 148(3): 790-798, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872652
16.
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
BMC Pulm Med
; 21(1): 301, 2021 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556083
17.
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Clin Exp Allergy
; 50(12): 1342-1351, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32909660
18.
A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma.
J Immunol
; 198(8): 3307-3317, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275137
19.
IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in Asthma.
Am J Respir Crit Care Med
; 197(3): 313-324, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29064281
20.
A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers.
BMC Pulm Med
; 19(1): 5, 2019 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616547